Search Results 561-570 of 3511 for 搜索引擎留痕工具咨询邮箱：lgooxc@hotmail.com

1. Abhishek A. Mangaonkar, M.B.B.S. - Mayo Clinic Faculty Profiles

   Abhishek A. Mangaonkar, M.B.B.S., studies the immune microenvironment of myeloid cancers and bone marrow failure syndromes.

2. Asthma Ascertainment and Characterization through Electronic Health Records - Mayo Clinic

   The purpose of this study is to look to see if automated chart review by computer predicts asthma status and asthma status characterization. Participation ...

3. A Study to Identify Microbiome Markers Associated with Preterm Labor - Mayo Clinic

   The purpose of this study is to identify components of the vaginal microbiology environment that contribute to the occurance of preterm labor and preterm ...

4. Laboratories - Mayo Clinic Research

   Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...

5. A Study to Assess the Safety, Tolerability and Effectiveness of LJN452 for Treating Patients who have Primary Biliary Cholangitis - Mayo Clinic

   The purpose of this study is to assess the safety, tolerability and effectiveness of LJN452 for the treatment of patients who have primary biliary cholangitis.

6. A Study to Find RNA Markers that Describe the Underlying Inflammatory Process and Can Help Direct Therapy - Mayo Clinic

   The purpose of the study is to find specific and sensitive RNA markers that not only describe the underlying inflammatory process, but can help direct therapy ...

7. S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma - Mayo Clinic

   Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, work ...

8. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

   All patients who complete the 52-week double-blind treatment period on IP may be eligible to continue into an open label extension (OLE) period. The OLE period ...

9. HTN Management and Cardiovascular Adverse Event Prevention in B-Cell Malignancies Undergoing BTKi - Mayo Clinic

   The purpose of this study is to prospectively define the incidence of new and/or worsening hypertension in patients with B-cell malignancies on Bruton Tyrosine ...

10. Publications - Hong Liang, D.O. - Mayo Clinic

    Lorenzo, Hong, Ian, Si, Jorge, Stephen Aniskevich III, Sadia, Dana, Wesley, Nathan, Liu, Pramod , Candido, Pablo, Tathagat.